{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T14:34:48Z","timestamp":1784212488756,"version":"3.55.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T00:00:00Z","timestamp":1688083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T00:00:00Z","timestamp":1688083200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006752","name":"Universidade do Porto","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006752","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Probiotics &amp; Antimicro. Prot."],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>Oral mucositis (OM) is an acute and highly prevalent side effect of cancer treatments. Currently, there is no effective strategy for its prevention or treatment. This systematic review aimed to assess the effectiveness of biotics used as a therapeutic strategy for the management of OM.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Materials and Methods<\/jats:title>\n                <jats:p>The PRISMA checklist was followed and PubMed, Web of Science, and Scopus were screened for clinical and pre-clinical studies assessing the potential effects of biotics in OM. Inclusion criteria included in vivo studies related to oral mucositis evaluating the effect of biotics, and written in Portuguese, English, French, Spanish, or Dutch. The following exclusion criteria were used: systematic reviews and meta-analyses, reviews, case reports, opinion papers or comments, conference papers, letters without results, articles not related to oral therapy-induced mucositis or biotics, or in vitro articles that do not simulate oral mucositis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>From a total of 1250 articles retrieved, 9 were included in this systematic review. Four clinical studies reported a reduction in oral mucositis occurrence with <jats:italic>Lactobacillus<\/jats:italic> species (<jats:italic>Lactobacillus casei<\/jats:italic> and <jats:italic>Lactobacillus brevis<\/jats:italic> CD2) and <jats:italic>Bacillus clausii<\/jats:italic> UBBC07. In pre-clinical studies, <jats:italic>Lactococcus lactis<\/jats:italic> genetically modified and <jats:italic>Lactobacillus reuteri<\/jats:italic> reduced the severity of OM and <jats:italic>Streptococcus salivarius<\/jats:italic> K12 also decreased the size of the ulcers.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The findings of this systematic review suggest that probiotic supplementation may potentially reduce the incidence of therapy-induced OM and decrease its severity in patients undergoing cancer treatment. However, the available evidence is marred by significant heterogeneity across studies.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s12602-023-10116-z","type":"journal-article","created":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T09:03:15Z","timestamp":1688115795000},"page":"1313-1326","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["The Role of Biotics as a Therapeutic Strategy for Oral Mucositis - A Systematic Review"],"prefix":"10.1007","volume":"16","author":[{"given":"Leonor","family":"Frey-Furtado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00eas","family":"Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jo\u00e3o","family":"Azevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedita","family":"Sampaio-Maia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,30]]},"reference":[{"key":"10116_CR1","doi-asserted-by":"publisher","unstructured":"Seiler S, Kosse J, Loibl S, Jackisch C (2014) Adverse event management of oral mucositis in patients with breast cancer. Breast Care 9(4). https:\/\/doi.org\/10.1159\/000366246","DOI":"10.1159\/000366246"},{"key":"10116_CR2","doi-asserted-by":"publisher","unstructured":"Kwon Y (2016) Mechanism-based management for mucositis: option for treating side effects without compromising the efficacy of cancer therapy. Onco Targets Ther 9. https:\/\/doi.org\/10.2147\/OTT.S96899","DOI":"10.2147\/OTT.S96899"},{"key":"10116_CR3","unstructured":"S.T. S. Pathobiology of oral mucositis: novel insights and opportunities. J Supportive Oncol. ;5(9 SUPPL. 4)."},{"key":"10116_CR4","doi-asserted-by":"publisher","unstructured":"Hou J, Zheng HM, Li P, Liu HY, Zhou HW, Yang XJ (2018) Distinct shifts in the oral microbiota are associated with the progression and aggravation of mucositis during radiotherapy. Radiother Oncol 129(1). https:\/\/doi.org\/10.1016\/j.radonc.2018.04.023","DOI":"10.1016\/j.radonc.2018.04.023"},{"key":"10116_CR5","doi-asserted-by":"publisher","unstructured":"Lalla R, Saunders DP, Peterson DE (2014) Chemotherapy or Radiation-Induced oral mucositis. Dent Clin North Am 58(2). https:\/\/doi.org\/10.1016\/j.cden.2013.12.005","DOI":"10.1016\/j.cden.2013.12.005"},{"key":"10116_CR6","doi-asserted-by":"publisher","unstructured":"Brown TJ, Gupta A (2020) Management of cancer therapy-associated oral mucositis. J Oncol Pract 16(3). https:\/\/doi.org\/10.1200\/JOP.19.00652","DOI":"10.1200\/JOP.19.00652"},{"key":"10116_CR7","doi-asserted-by":"publisher","unstructured":"Degruttola AK, Low D, Mizoguchi A, Mizoguchi E (2016) Current understanding of dysbiosis in disease in human and animal models. Inflamm Bowel Dis 22(5). https:\/\/doi.org\/10.1097\/MIB.0000000000000750","DOI":"10.1097\/MIB.0000000000000750"},{"key":"10116_CR8","doi-asserted-by":"publisher","unstructured":"Xu Y, Teng F, Huang S et al (2014) Changes of saliva microbiota in nasopharyngeal carcinoma patients under chemoradiation therapy. Arch Oral Biol 59(2). https:\/\/doi.org\/10.1016\/j.archoralbio.2013.10.011","DOI":"10.1016\/j.archoralbio.2013.10.011"},{"key":"10116_CR9","doi-asserted-by":"publisher","unstructured":"Elad S, Cheng KKF, Lalla R et al (2020) MASCC\/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer 126(19). https:\/\/doi.org\/10.1002\/cncr.33100","DOI":"10.1002\/cncr.33100"},{"key":"10116_CR10","unstructured":"E C, M C, R C. Probiotics and mucositis. Curr Opin Clin Nutr Metab Care. ;21(5)"},{"key":"10116_CR11","doi-asserted-by":"publisher","unstructured":"Salminen S, Collado MC, Endo A et al (2021) The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics. Nat Rev Gastroenterol Hepatol 18(9). https:\/\/doi.org\/10.1038\/s41575-021-00440-6","DOI":"10.1038\/s41575-021-00440-6"},{"key":"10116_CR12","doi-asserted-by":"publisher","unstructured":"Szajewska H, Mrukowicz JZ (2001) Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: a systematic review of published randomized, double-blind, placebo-controlled trials. J Pediatr Gastroenterol Nutr 33. https:\/\/doi.org\/10.1097\/00005176-200110002-00004","DOI":"10.1097\/00005176-200110002-00004"},{"key":"10116_CR13","doi-asserted-by":"publisher","unstructured":"Matsubara VH, Bandara HMHN, Ishikawa KH, Mayer MPA, Samaranayake LP (2016) The role of probiotic bacteria in managing periodontal disease: a systematic review. Expert Rev Anti Infect Ther 14(7). https:\/\/doi.org\/10.1080\/14787210.2016.1194198","DOI":"10.1080\/14787210.2016.1194198"},{"key":"10116_CR14","doi-asserted-by":"publisher","unstructured":"Christian H, Suharsini M, Fauziah E (2020) Effects of probiotics on clinical appearance of oral mucositis in children with leukemia during chemotherapy. Int J Dent Oral Sci 7(11). https:\/\/doi.org\/10.19070\/2377-8075-20000204","DOI":"10.19070\/2377-8075-20000204"},{"key":"10116_CR15","doi-asserted-by":"publisher","unstructured":"de Sanctis V, Belgioia L, Cante D et al (2019) Lactobacillus brevis CD2 for Prevention of oral Mucositis in patients with Head and Neck Tumors: a multicentric randomized study. Anticancer Res 39(4). https:\/\/doi.org\/10.21873\/anticanres.13303","DOI":"10.21873\/anticanres.13303"},{"key":"10116_CR16","doi-asserted-by":"publisher","unstructured":"Sharma A, Tilak T, Bakhshi S et al (2016) Lactobacillus brevis CD2 lozenges prevent oral mucositis in patients undergoing high dose chemotherapy followed by haematopoietic stem cell transplantation. ESMO Open 1. https:\/\/doi.org\/10.1136\/esmoopen-2016-000138","DOI":"10.1136\/esmoopen-2016-000138"},{"key":"10116_CR17","doi-asserted-by":"publisher","unstructured":"Sharma A, Rath GK, Chaudhary SP, Thakar A, Mohanti BK, Bahadur S (2012) Lactobacillus brevis CD2 lozenges reduce radiation- and chemotherapy-induced mucositis in patients with head and neck cancer: a randomized double-blind placebo-controlled study. Eur J Cancer 48(6). https:\/\/doi.org\/10.1016\/j.ejca.2011.06.010","DOI":"10.1016\/j.ejca.2011.06.010"},{"key":"10116_CR18","doi-asserted-by":"publisher","unstructured":"Topuz E, Derin D, Can G et al (2008) Effect of oral administration of kefir on serum proinflammatory cytokines on 5-FU induced oral mucositis in patients with colorectal cancer. Invest New Drugs 26(6). https:\/\/doi.org\/10.1007\/s10637-008-9171-y","DOI":"10.1007\/s10637-008-9171-y"},{"key":"10116_CR19","doi-asserted-by":"publisher","unstructured":"Mirza MA, Aruna D, Irukulla M (2022) Efficacy of Bacillus clausii UBBC \u2013 07 spores in the amelioration of oral mucositis in head and neck cancer patients undergoing radiation therapy. Cancer Treat Res Commun 31. https:\/\/doi.org\/10.1016\/j.ctarc.2022.100523","DOI":"10.1016\/j.ctarc.2022.100523"},{"key":"10116_CR20","doi-asserted-by":"publisher","unstructured":"Wang Y, Li J, Zhang H et al (2021) Probiotic Streptococcus salivarius K12 alleviates Radiation-Induced oral mucositis in mice. Front Immunol 12. https:\/\/doi.org\/10.3389\/fimmu.2021.684824","DOI":"10.3389\/fimmu.2021.684824"},{"key":"10116_CR21","doi-asserted-by":"publisher","unstructured":"Caluwaerts S, Vandenbroucke K, Steidler L et al (2010) AG013, a mouth rinse formulation of Lactococcus lactis secreting human Trefoil factor 1, provides a safe and efficacious therapeutic tool for treating oral mucositis. Oral Oncol 46(7). https:\/\/doi.org\/10.1016\/j.oraloncology.2010.04.008","DOI":"10.1016\/j.oraloncology.2010.04.008"},{"key":"10116_CR22","doi-asserted-by":"publisher","unstructured":"Gupta N, Ferreira J, Hong CHL, Tan KS (2020) Lactobacillus reuteri DSM 17938 and ATCC PTA 5289 ameliorates chemotherapy-induced oral mucositis. Sci Rep 10(1). https:\/\/doi.org\/10.1038\/s41598-020-73292-w","DOI":"10.1038\/s41598-020-73292-w"},{"key":"10116_CR23","doi-asserted-by":"publisher","unstructured":"Mirza MA, Aruna D, Irukulla M (2022) Efficacy of Bacillus clausii UBBC \u2013 07 spores in the amelioration of oral mucositis in head and neck cancer patients undergoing radiation therapy. Cancer Treat Res Commun 31. https:\/\/doi.org\/10.1016\/j.ctarc.2022.100523","DOI":"10.1016\/j.ctarc.2022.100523"},{"key":"10116_CR24","doi-asserted-by":"publisher","unstructured":"Llewellyn A, Foey A (2017) Probiotic modulation of innate cell pathogen sensing and signaling events. Nutrients 9(10). https:\/\/doi.org\/10.3390\/nu9101156","DOI":"10.3390\/nu9101156"},{"key":"10116_CR25","doi-asserted-by":"publisher","unstructured":"Cristofori F, Dargenio VN, Dargenio C, Miniello VL, Barone M, Francavilla R (2021) Anti-inflammatory and Immunomodulatory Effects of Probiotics in Gut inflammation: a door to the body. Front Immunol 12. https:\/\/doi.org\/10.3389\/fimmu.2021.578386","DOI":"10.3389\/fimmu.2021.578386"},{"key":"10116_CR26","unstructured":"Lee JM, Hwang KT, Jun WJ, Park CS, Lee MY (2008) Antiinflammatory effect of lactic acid bacteria: inhibition of cyclooxygenase-2 by suppressing nuclear factor-\u03baB in Raw264.7 macrophage cells. J Microbiol Biotechnol. ;18(10)"},{"key":"10116_CR27","doi-asserted-by":"publisher","unstructured":"Amdekar S, Singh V, Singh R, Sharma P, Keshav P, Kumar A (2011) Lactobacillus casei reduces the inflammatory joint damage associated with collagen-induced arthritis (CIA) by reducing the pro-inflammatory cytokines - Lactobacillus casei: COX-2 inhibitor. J Clin Immunol 31(2). https:\/\/doi.org\/10.1007\/s10875-010-9457-7","DOI":"10.1007\/s10875-010-9457-7"},{"key":"10116_CR28","doi-asserted-by":"publisher","unstructured":"Szkaradkiewicz AK, Stopa J, Karpi\u0144ski TM (2014) Effect of oral administration involving a probiotic strain of Lactobacillus reuteri on pro-inflammatory cytokine response in patients with chronic Periodontitis. Arch Immunol Ther Exp (Warsz) 62(6). https:\/\/doi.org\/10.1007\/s00005-014-0277-y","DOI":"10.1007\/s00005-014-0277-y"},{"key":"10116_CR29","doi-asserted-by":"publisher","unstructured":"Mu Q, Tavella VJ, Luo XM (2018) Role of Lactobacillus reuteri in human health and diseases. Front Microbiol 9(APR). https:\/\/doi.org\/10.3389\/fmicb.2018.00757","DOI":"10.3389\/fmicb.2018.00757"},{"key":"10116_CR30","doi-asserted-by":"publisher","unstructured":"Ghelardi E, Abreu Y, Abreu AT, Marzet CB, Calatayud G, Perez MIII, Castro APM (2022) Current progress and future perspectives on the use of Bacillus clausii. Microorganisms 10(6). https:\/\/doi.org\/10.3390\/microorganisms10061246","DOI":"10.3390\/microorganisms10061246"},{"key":"10116_CR31","doi-asserted-by":"publisher","unstructured":"Nirmala M, Smitha SG, Kamath GJ (2019) A study to assess the efficacy of local application of oral probiotic in treating recurrent aphthous ulcer and oral candidiasis. Indian J Otolaryngol Head Neck Surg 71. https:\/\/doi.org\/10.1007\/s12070-017-1139-9","DOI":"10.1007\/s12070-017-1139-9"},{"key":"10116_CR32","doi-asserted-by":"publisher","unstructured":"Burton JP, Chilcott CN, Moore CJ, Speiser G, Tagg JR (2006) A preliminary study of the effect of probiotic Streptococcus salivarius K12 on oral malodour parameters. J Appl Microbiol 100(4). https:\/\/doi.org\/10.1111\/j.1365-2672.2006.02837.x","DOI":"10.1111\/j.1365-2672.2006.02837.x"},{"key":"10116_CR33","doi-asserted-by":"publisher","unstructured":"van der Waal MB, Flach J, Browne PD, Besseling-van der Vaart I, Claassen E, van de Burgwal LHM (2019) Probiotics for improving quality of life in ulcerative colitis: exploring the patient perspective. PharmaNutrition 7. https:\/\/doi.org\/10.1016\/j.phanu.2018.100139","DOI":"10.1016\/j.phanu.2018.100139"},{"key":"10116_CR34","doi-asserted-by":"publisher","unstructured":"Carvalho R, Vaz A, Pereira FL et al (2018) Gut microbiome modulation during treatment of mucositis with the dairy bacterium Lactococcus lactis and recombinant strain secreting human antimicrobial PAP. Sci Rep 8(1). https:\/\/doi.org\/10.1038\/s41598-018-33469-w","DOI":"10.1038\/s41598-018-33469-w"},{"key":"10116_CR35","doi-asserted-by":"publisher","unstructured":"Wallace TC, MacKay D (2011) The safety of probiotics: considerations following the 2011 U.S. agency for health research and quality report. J Nutr 141(11). https:\/\/doi.org\/10.3945\/jn.111.147629","DOI":"10.3945\/jn.111.147629"},{"key":"10116_CR36","unstructured":"FAO\/WHO. Guidelines for the evaluation of probiotics in food. Food and Agriculture Organization of the United Nations and World Health Organization Group Report.(London Ontario, Canada). FAO Food and Nutrition Paper 85. Published online 2002"},{"key":"10116_CR37","unstructured":"Food Supplements Europe (2021) Probiotics: Growing Science and Need for Proper Consumer Communication on Probiotic Food Supplements.;"},{"key":"10116_CR38","doi-asserted-by":"publisher","unstructured":"Mohammadi F, Oshvandi K, Kamallan SR et al (2022) Effectiveness of sodium bicarbonate and zinc chloride mouthwashes in the treatment of oral mucositis and quality of life in patients with cancer under chemotherapy. Nurs Open 9(3). https:\/\/doi.org\/10.1002\/nop2.1168","DOI":"10.1002\/nop2.1168"},{"key":"10116_CR39","doi-asserted-by":"publisher","unstructured":"Huynh NCN, Everts V, Leethanakul C, Pavasant P, Ampornaramveth RS (2016) Rinsing with saline promotes human gingival fibroblast wound healing in vitro. PLoS ONE 11(7). https:\/\/doi.org\/10.1371\/journal.pone.0159843","DOI":"10.1371\/journal.pone.0159843"}],"container-title":["Probiotics and Antimicrobial Proteins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-023-10116-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12602-023-10116-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-023-10116-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T13:13:30Z","timestamp":1723554810000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12602-023-10116-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,30]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["10116"],"URL":"https:\/\/doi.org\/10.1007\/s12602-023-10116-z","relation":{},"ISSN":["1867-1306","1867-1314"],"issn-type":[{"value":"1867-1306","type":"print"},{"value":"1867-1314","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,30]]},"assertion":[{"value":"22 June 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"None declared.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflit of Interest"}}]}}